Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metformin and gestational diabetes.

Charles J Glueck1, Naila Goldenberg, Patricia Streicher

  • 1Jewish Hospital Cholesterol Center, ABC Building, 3200 Burnet Avenue, Cincinnati, OH 45229, USA. glueckch@healthall.com

Current Diabetes Reports
|July 18, 2003
PubMed
Summary

Metformin may help prevent gestational diabetes (GD) by reducing insulin resistance during pregnancy. This approach aims to protect pancreatic beta-cell function and lower the risk of developing type 2 diabetes mellitus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombophilia, hypofibrinolysis and osteonecrosis.

Orthopadie (Heidelberg, Germany)·2025
Same author

Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?

The Journal of clinical endocrinology and metabolism·2024
Same author

Familial Thrombophilia Is Associated With Primary Multifocal Osteonecrosis: A Case-Control Study of 40 Patients.

Orthopedics·2023
Same author

Long-term Anticoagulation Prevents Progression of Stages I and II Primary Osteonecrosis of the Hip in Patients With Familial Thrombophilia.

Orthopedics·2020
Same author

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events.

Journal of clinical medicine·2018
Same author

Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics.

Metabolism: clinical and experimental·2018

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Reproductive Medicine

Background:

  • Pregnancy elevates insulin requirements, exacerbating insulin resistance and stressing pancreatic beta cells.
  • This physiological state increases the risk of gestational diabetes (GD), especially in women with pre-existing insulin resistance, such as those with polycystic ovary syndrome.

Purpose of the Study:

  • To explore the potential of metformin in preventing the development of gestational diabetes.
  • To investigate interventions that reduce insulin resistance and endogenous insulin secretion demands.

Main Methods:

  • Review of preliminary studies on metformin's efficacy in preventing GD.
  • Postulation of therapeutic strategies targeting insulin resistance and beta-cell preservation.

Related Experiment Videos

Main Results:

  • Preliminary data suggests metformin may possess unique properties for GD prevention.
  • Interventions reducing insulin resistance are hypothesized to preserve beta-cell function.

Conclusions:

  • Metformin shows promise as a preventative agent for gestational diabetes.
  • Reducing insulin resistance and endogenous insulin demand may prevent both GD and type 2 diabetes mellitus.